Cardinal Health, Inc. (NYSE:CAH)

Marco Green
November 3, 2017

Cardinal Health, Inc. (NYSE:CAH) reported its EPS in the last quarter as $1.31/Share beating the analyst estimate of $1.24/Share by a difference of $0.07. The daily trading volume has averaged 2.47 million shares a day in past 3 months.

Other institutional investors also recently bought and sold shares of the company.

Cardinal Health, Inc. most recently reported earnings per share (EPS) of $1.31 for the June 2017 versus $1.14 in the same quarter past year, representing 15% growth.

About 471,024 shares traded. It also reduced its holding in Ptc Inc (NASDAQ:PTC) by 18,143 shares in the quarter, leaving it with 34,570 shares, and cut its stake in Broadcom Ltd. Origin Asset Management LLP now owns 377,381 shares of the company's stock valued at $30,926,000 after buying an additional 161,881 shares during the period. Alpha Windward LLC raised its position in shares of Cardinal Health by 0.7% during the second quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Cardinal Health by 0.3% during the second quarter. Bessemer Group Inc. now owns 4,238 shares of the company's stock worth $330,000 after purchasing an additional 51 shares during the period. The company's revenue for the quarter was up 5.0% compared to the same quarter past year. Hedge funds and other institutional investors own 85.78% of the company's stock. 718,730 are held by Mcdonald Investors Incorporated Ca. Rampart Investment Mngmt Co Limited Liability Corporation reported 1,521 shares. The stock is now moving below its 20-Day Simple Moving Average of -5.66% with a 50-Day Simple Moving Average of -7.07 percent.

Cardinal Health, Inc. (NYSE:CAH) received a Buy rating from 2 analysts. As of the last earnings report the EPS was $4.03 and is estimated to be $4.95 for the current year with 316,453,000 shares outstanding.

Analysts believe that the company has the potential to earn average revenue of $33.48 Billion for the current quarter. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The company's revenue for the quarter was up 13.9% compared to the same quarter a year ago. During the same quarter a year ago, the firm posted $1.14 earnings per share. Jefferies Group LLC reissued a "hold" rating and set a $77.00 price target on shares of Cardinal Health in a research report on Thursday, July 27th.

The business also recently announced a quarterly dividend, which was paid on Saturday, October 15th.

Investors sentiment decreased to 0.84 in Q2 2017. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date was Friday, September 29th. Cardinal Health's dividend payout ratio is now 45.79%.

Several equities analysts recently weighed in on the stock. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company. The company was maintained on Thursday, August 4 by Deutsche Bank. Zacks downgraded the shares of CAH in report on Monday, August 10 to "Buy" rating.

Cardinal Health, Inc. (NYSE:CAH) touched its 1-Year High price of $84.88 on 03/14/17 and its 1-Year Low price of $60.69 on 10/31/17. Finally, BidaskClub lowered Cardinal Health from a "sell" rating to a "strong sell" rating in a research report on Wednesday, August 16th. The stock of Cardinal Health Inc (NYSE:CAH) has "Buy" rating given on Thursday, December 17 by Goldman Sachs. If the $58.05 price target is reached, the company will be worth $762.40M less. The stock was sold at an average price of $83.76, for a total value of $10,873,555.68. Ameriprise Financial Inc. now owns 3,557,123 shares of the company's stock valued at $277,191,000 after acquiring an additional 1,482,285 shares during the last quarter.

Ameritas Investment Partners Inc increased its stake in Teradata Corp Del (TDC) by 1272.39% based on its latest 2017Q2 regulatory filing with the SEC. They set a "sector perform" rating and a $72.00 target price on the stock. The disclosure for this sale can be found here.

Analysts are turning out to be more optimistic than before, with 2 of analysts who cover Cardinal Health, Inc. The Company operates in two segments: Pharmaceutical and Medical. The Company provides solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices across the world. In the United States, the Company's Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers.

Other reports by Click Lancashire

Discuss This Article